DUBLIN–(BUSINESS WIRE)–The “Biochips Market Report, By Technology, By Application, By Product Type, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The biochips market size is estimated to be USD 15,136 million in 2021 and is expected to witness a CAGR of 13.51% during the forecast period 2022-2029. The growing use of targeted and customised treatment worldwide, the expansion of biochip applications, and technological innovation are the factors contributing to the market growth. However, costly instrumentation and ambiguous regulatory standards are expected to hinder the growth.
By Technology
Based on technology, the market is segmented into microarray and microfluidics. In 2021, the microfluidics segment accounted for the largest revenue share owing to increased demand for POC diagnostic devices like glucose monitoring and pregnancy test kits.
Segmentation: Biochips Market Report 2021-2029
By Technology (Revenue, USD Million)
- Microarray
- Microfluidics
By Application (Revenue, USD Million)
- In-Vitro Diagnostics
- Proteomics
- Genomics
- Drug Discovery & Development
Product Type (Revenue, USD Million)
- Protein Chips
- Lab-On-A-Chip
- DNA Chips
By Region (Revenue, USD Million)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Biochips
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Biochips Market
7. Market Analysis by Technology
8. Market Analysis by Application
9. Market Analysis by Product Type
10. Regional Market Analysis
11. North America Biochips Market
12. Europe Biochips Market
13. Asia Pacific Biochips Market
14. Latin America Biochips Market
15. MEA Biochips Market
16. Competitor Analysis
17. Company Profiles
18. Conclusion & Recommendations
Companies Mentioned
- Abbott Laboratories (US)
- Agilent Technologies Inc. (US)
- PerkinElmer Inc. (US)
- Fluidigm Corporation (US)
- Illumina Inc. (US)
- GE Healthcare (US)
- Bio-Rad Laboratories Inc. (US)
- Cepheid Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- F. Hoffmann-La Roche AG (Switzerland).
For more information about this report visit https://www.researchandmarkets.com/r/5y7d9h
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
